𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Human marginal-zone B cells

✍ Scribed by Jo Spencer; Marta E Perry; Deborah K Dunn-Walters


Publisher
Elsevier Science
Year
1998
Tongue
English
Weight
779 KB
Volume
19
Category
Article
ISSN
0167-5699

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Marginal zone B cells in lymphocyte acti
✍ Thiago Lopes-Carvalho; Jeremy Foote; John F Kearney πŸ“‚ Article πŸ“… 2005 πŸ› Elsevier Science 🌐 English βš– 401 KB

Marginal zone (MZ) B cells, together with other strategically located innate cells, constitute the first line of defense against blood-borne microorganisms, viruses and toxins in the spleen. Their fast and efficient protective antibody responses are well characterized; however, much less is known of

Foxo1 regulates marginal zone B-cell dev
✍ Jing Chen; Jose J. Limon; Caroline Blanc; Stanford L. Peng; David A. Fruman πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 345 KB

## Abstract A fundamental component of signaling initiated by the BCR and CD19 is the activation of phosphoinositide 3‐kinase. Downstream of phosphoinositide 3‐kinase, the protein kinase AKT phosphorylates several substrates, including members of the forkhead box subgroup O (Foxo) transcription fac

Genetic abnormalities in marginal zone B
✍ Judith Dierlamm; Iwona Wlodarska; Lucienne Michaux; Margarita Stefanova; Kristin πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 182 KB πŸ‘ 2 views

Marginal zone B-cell lymphoma (MZBCL) including extranodal mucosa-associated lymphoid tissue (MALT)-type lymphoma, nodal, and splenic MZBCL represents a distinct subtype of B-non-Hodgkin's lymphoma. Recently, important progress in the elucidation of the genetic mechanisms underlying the pathogenesis

Nodal and splenic marginal zone B cell l
✍ Manuela Mollejo; Francisca I Camacho; Patricia Algara; Elena Ruiz-Ballesteros; J πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 757 KB

## Abstract Splenic marginal zone lymphoma (SMZL) and nodal marginal zone lymphoma (NMZL) are newly defined, separate clinicopathological entities. Both are rare lymphoma types, with low reproducibility in the diagnosis, although a conjunction of molecular and clinical studies seems to be now facil